Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

NCT06120036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 1

Interventions

DRUG: Kybella
DRUG: Asclera

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]